Page 1 of Clinical Trials for Drug fluticasone propionate salmeterol powder, 26 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study Of Asthma In Patients Of African Descent
Last Updated: March 10, 2011
Condition(s): Asthma
2
Completed
Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease
Last Updated: March 17, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Osteoporosis; Chronic Obstructive Airway Disease; Osteopenia
3
Completed
Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
Last Updated: December 17, 2010
Condition(s): Asthma
4
Completed
HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents
Last Updated: September 21, 2011
Condition(s): Asthma
5
Completed
Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe COPD Patients.
Last Updated: December 21, 2011
Condition(s): Asthma
6
Completed
Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: January 19, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
7
Not yet recruiting
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Last Updated: January 19, 2012
Condition(s): Chronic Obstructive Pulmonary Disease
8
Active, not recruiting
A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))
Last Updated: October 13, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
9
Completed
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease
Last Updated: February 9, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
10
Completed
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: February 9, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
11
Completed
Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
Last Updated: February 9, 2012
Condition(s): Asthma
12
Completed
Real-world Effectiveness of Combination Therapy in Asthma
Last Updated: June 9, 2010
Condition(s): Asthma
13
Completed
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS 250/50mcg Plus SPIRIVA HANDIHALER Versus SPIRIVA HANDIHALER Plus Placebo DISKUS in Subjects With Chronic Obstructive Pulmonary Disease (COPD). SPIRIVA and HANDIHALER Are Trade Marks of Boehringer Ingelheim
Last Updated: December 15, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
14
Completed
Bronchodilatory Efficacy of a Single Dose QMF149 Via a Multiple-Dose Dry Powder Inhaler (MDDPI) in Adult Asthma Patients
Last Updated: March 16, 2009
Condition(s): Asthma
15
Completed
Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)
Last Updated: December 28, 2011
Condition(s): Asthma
16
Active, not recruiting
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Last Updated: February 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
17
Completed
Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids
Last Updated: September 1, 2011
Condition(s): Asthma
18
Not yet recruiting
Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD
Last Updated: July 12, 2011
Condition(s): Chronic Obstructive Pulmonary Disease; COPD
19
Active, not recruiting
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age
Last Updated: November 10, 2011
Condition(s): Asthma
20
Active, not recruiting
QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: September 5, 2011
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+fluticasone+propionate+salmeterol+powder

Page 1 of Clinical Trials for Drug fluticasone propionate salmeterol powder, 26 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About